Early Access — free while we kick the tires
EdgarHawk

DICICCO WENDY F

Director

Director
1 filing analyzed · 1 company · Latest 2024-08-21

Companies

Company Buys Sells Direction
EyePoint Pharmaceuticals, Inc. EYPT 1 0 Net buying

Activity

August 2024
Buy
2,567 shares
$19,997
Significance 6/10

Director buys 2,567 shares of EYPT at $7.79 on 2024-08-20; 3 other insiders bought in past 14 days

Director Dicicco purchased 2,567 shares at $7.79, increasing her holdings by 34.7% to 9,967 shares. This purchase is part of a broader cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated confidence. The transaction occurred when the stock was trading 69.5% below its 52-week high of $29.71, though the company has posted negative net income of $-30,826,000.00 over its most recent full fiscal year. The concurrence of multiple insider buys at depressed valuations warrants tracking whether this precedes company-level developments or represents a fundamental reassessment of risk.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access